Characterizing intra-tumor regions on quantitative ultrasound parametric images to predict breast cancer response to chemotherapy at pre-treatment

被引:16
|
作者
Taleghamar, Hamidreza [1 ]
Moghadas-Dastjerdi, Hadi [2 ,3 ,4 ]
Czarnota, Gregory J. [2 ,3 ,4 ]
Sadeghi-Naini, Ali [1 ,2 ,3 ,4 ]
机构
[1] York Univ, Lassonde Sch Engn, Dept Elect Engn & Comp Sci, Toronto, ON, Canada
[2] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[3] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada
[4] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Dept Radiat Oncol, Toronto, ON, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
PATHOLOGICAL COMPLETE RESPONSE; BACKSCATTER COEFFICIENT MEASUREMENTS; POSITRON-EMISSION-TOMOGRAPHY; NEOADJUVANT CHEMOTHERAPY; THERAPY RESPONSE; WOMEN; BIOMARKERS; MODEL;
D O I
10.1038/s41598-021-94004-y
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The efficacy of quantitative ultrasound (QUS) multi-parametric imaging in conjunction with unsupervised classification algorithms was investigated for the first time in characterizing intra-tumor regions to predict breast tumor response to chemotherapy before the start of treatment. QUS multi-parametric images of breast tumors were generated using the ultrasound radiofrequency data acquired from 181 patients diagnosed with locally advanced breast cancer and planned for neo-adjuvant chemotherapy followed by surgery. A hidden Markov random field (HMRF) expectation maximization (EM) algorithm was applied to identify distinct intra-tumor regions on QUS multi-parametric images. Several features were extracted from the segmented intra-tumor regions and tumor margin on different parametric images. A multi-step feature selection procedure was applied to construct a QUS biomarker consisting of four features for response prediction. Evaluation results on an independent test set indicated that the developed biomarker coupled with a decision tree model with adaptive boosting (AdaBoost) as the classifier could predict the treatment response of patient at pre-treatment with an accuracy of 85.4% and an area under the receiver operating characteristic (ROC) curve (AUC) of 0.89. In comparison, the biomarkers consisted of the features derived from the entire tumor core (without consideration of the intra-tumor regions), and the entire tumor core and the tumor margin could predict the treatment response of patients with an accuracy of 74.5% and 76.4%, and an AUC of 0.79 and 0.76, respectively. Standard clinical features could predict the therapy response with an accuracy of 69.1% and an AUC of 0.6. Long-term survival analyses indicated that the patients predicted by the developed model as responders had a significantly better survival compared to the non-responders. Similar findings were observed for the two response cohorts identified at post-treatment based on standard clinical and pathological criteria. The results obtained in this study demonstrated the potential of QUS multi-parametric imaging integrated with unsupervised learning methods in identifying distinct intra-tumor regions in breast cancer to characterize its responsiveness to chemotherapy prior to the start of treatment.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] The Presence of an In Situ Component on Pre-Treatment Biopsy Is Not Associated with Response to Neoadjuvant Chemotherapy for Breast Cancer
    Labrosse, Julie
    Morel, Charlotte
    Lam, Thanh
    Laas, Enora
    Feron, Jean-Guillaume
    Coussy, Florence
    Lae, Marick
    Reyal, Fabien
    Hamy, Anne-Sophie
    CANCERS, 2021, 13 (02) : 1 - 12
  • [22] Intra-tumor heterogeneity as a predictor of therapy response in HER2 positive breast cancer
    Rye, I. H.
    Helland, A.
    Saetersdal, A.
    Naume, B.
    Almendro, V.
    Polyak, K.
    Boressen-Dale, A-L
    Russnes, H. G.
    CANCER RESEARCH, 2012, 72
  • [23] Notch signaling mutations increase intra-tumor chemokine expression and predict response to immunotherapy in colorectal cancer
    Wang, Fei
    Huang, Chuan
    Long, Jie
    Zhao, Zhi-Bin
    Ma, Hai-Qing
    Yao, Xue-Qing
    Li, Liang
    Lian, Zhe-Xiong
    BMC CANCER, 2022, 22 (01)
  • [24] Breast MRI radiomics for the pre-treatment prediction of response to neoadjuvant chemotherapy in node-positive breast cancer patients
    Drukker, Karen
    El-Bawab, Iman
    Edwards, Alexandra
    Doyle, Christopher
    Papaioannou, John
    Kulkarni, Kirti
    Giger, Maryellen L.
    MEDICAL IMAGING 2019: COMPUTER-AIDED DIAGNOSIS, 2019, 10950
  • [25] Notch signaling mutations increase intra-tumor chemokine expression and predict response to immunotherapy in colorectal cancer
    Fei Wang
    Chuan Huang
    Jie Long
    Zhi-Bin Zhao
    Hai-Qing Ma
    Xue-Qing Yao
    Liang Li
    Zhe-Xiong Lian
    BMC Cancer, 22
  • [26] Pre-treatment circulating reproductive hormones levels predict pathological and survival outcomes in breast cancer submitted to neoadjuvant chemotherapy
    Lan, Ailin
    Jin, Yudi
    Wang, Yu
    Wang, Yihua
    Ding, Nan
    Dai, Yuran
    Jiang, Linshan
    Tang, Zhenrong
    Peng, Yang
    Liu, Shengchun
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (05) : 899 - 910
  • [27] Pre-treatment circulating reproductive hormones levels predict pathological and survival outcomes in breast cancer submitted to neoadjuvant chemotherapy
    Ailin Lan
    Yudi Jin
    Yu Wang
    Yihua Wang
    Nan Ding
    Yuran Dai
    Linshan Jiang
    Zhenrong Tang
    Yang Peng
    Shengchun Liu
    International Journal of Clinical Oncology, 2022, 27 : 899 - 910
  • [28] Identification of pre-treatment tumor habitats for the prediction of neoadjuvant therapy response in triple negative breast cancer
    Kazerouni, Anum S.
    Kennedy, Laura C.
    Vinayak, Shaveta
    Dintzis, Suzanne
    Rahbar, Habib
    Partridge, Savannah C.
    CANCER RESEARCH, 2022, 82 (12)
  • [29] Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer
    H. Raza Ali
    Aliakbar Dariush
    Elena Provenzano
    Helen Bardwell
    Jean E. Abraham
    Mahesh Iddawela
    Anne-Laure Vallier
    Louise Hiller
    Janet. A. Dunn
    Sarah J. Bowden
    Tamas Hickish
    Karen McAdam
    Stephen Houston
    Mike J. Irwin
    Paul D. P. Pharoah
    James D. Brenton
    Nicholas A. Walton
    Helena M. Earl
    Carlos Caldas
    Breast Cancer Research, 18
  • [30] Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer
    Ali, H. Raza
    Dariush, Aliakbar
    Provenzano, Elena
    Bardwell, Helen
    Abraham, Jean E.
    Iddawela, Mahesh
    Vallier, Anne-Laure
    Hiller, Louise
    Dunn, Janet. A.
    Bowden, Sarah J.
    Hickish, Tamas
    McAdam, Karen
    Houston, Stephen
    Irwin, Mike J.
    Pharoah, Paul D. P.
    Brenton, James D.
    Walton, Nicholas A.
    Earl, Helena M.
    Caldas, Carlos
    BREAST CANCER RESEARCH, 2016, 18